Applied Genetic Technologies (AGTC) Return on Assets ROA from the first quarter of 2023 to first quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket
 


Applied Genetic Technologies Corporation  (NASDAQ: AGTC)


Applied Genetic Technologies's ROA from the first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Applied Genetic Technologies's ROA in the first quarter of 2023?
Applied Genetic Technologies Corporation recorded a cumulative net loss of $-70 million during 12 months ending in the first quarter of 2023, resulting in a negative return on assets (ROA) of -93.64%.

However, within the Healthcare sector 970 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2022 quarter, so far to 5232, from total ROA ranking in the fourth quarter of 2022 at 5279.

What is ROA?



Return On Assets (Sep 30 2022)
I. Quarter
(Jun 30 2022)
IV. Quarter
(Mar 31 2022)
III. Quarter
(Dec 31 2021)
II. Quarter
(Sep 30 2021)
I. Quarter
Y / Y Total Assets Change -47.44 % -47.44 % -33.65 % 26.54 % 31.48 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -70 -69 -63 -63 -60
Return On Assets (TTM) -93.64 % -78.38 % -61.02 % -55.65 % -54.71 %
AGTC's Total Ranking # 5232 # 5279 # 5084 # 5376 # 4444
Total Assets (TTM) in million 57 66 86 91 109
Seq. Total Assets Change -12.39 % -23.85 % -5.52 % -16.61 % -12.39 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 150
Sector # 971
Overall # 5122

Return On Assets Statistics
High Average Low
30.68 %
-23.32 %
-92.54 %
(Sep 30 2014)   (Sep 30 2022)





Financial Statements
Applied Genetic Technologies's Assets $ 57 million AGTC's Balance sheet
Applied Genetic Technologies's Income $ -18 million Quarterly AGTC's Income Statement
AGTC's Income by Division See AGTC's Income by Division



Annual Return On Assets (Jun 30 2022)
FY 2022
(Jun 30 2021)
FY 2021
(Jun 30 2020)
FY 2020
(Jun 30 2019)
FY 2019
(Jun 30 2018)
FY 2018
Y / Y Total Assets Change -47.44 % 26.59 % 6.78 % -22.2 % -19.87 %
Total Assets in million 66 125 98 92 119
Y / Y Net Income Change - - - - -
Net Income in million -69 -58 -46 -2 -21
Annual Return On Assets -105.23 % -46.39 % -46.61 % -2.18 % -17.97 %




More Return On Assets Ratios
AGTC's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AGTC's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AGTC's Competitors
Subscribers only: Roa for Applied Genetic Technologies's Suppliers
Subscribers only: Return On Assets for AGTC's Customers

You may also want to know
AGTC's Roi AGTC's Inventory Turnover Ratio AGTC's Growth Rates AGTC's Dividend Comparisons
AGTC's Profitability Ratios AGTC's Asset Turnover Ratio AGTC's Dividend Growth
AGTC's Roe AGTC's Valuation Ratios AGTC's Financial Strength Ratios AGTC's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector ROA


Date modified: 2026-09-08T15:10:47+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.